Advertisement
Advertisement
AMPH
Amphastar Pharmaceuticals, Inc.
16.87
USDSponsored
-0.43
-2.49%
May 15, 15:59 UTC -4
Closed
After-Market
17.41
+0.54
+3.23%
AMPH Earnings Reports
Positive Surprise Ratio
AMPH beat 32 of 42 last estimates.
76%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$186.13M
/$0.72
Implied change from Q1 26 (Revenue/ EPS)
+8.74%
/+71.43%
Implied change from Q2 25 (Revenue/ EPS)
+6.72%
/-15.29%
Amphastar Pharmaceuticals, Inc. earnings per share and revenue
On May 07, 2026, AMPH reported earnings of 0.42 USD per share (EPS) for Q1 26, missing the estimate of 0.71 USD, resulting in a -41.59% surprise. Revenue reached 171.17 million, compared to an expected 176.86 million, with a -3.22% difference. The market reacted with a -20.93% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 0.72 USD, with revenue projected to reach 186.13 million USD, implying an increase of 71.43% EPS, and increase of 8.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Taysha Gene Therapies, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.12
Surprise
-20.48%
Personalis, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-5.42%
Assembly Biosciences, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.54
Surprise
+7.12%
BridgeBio Pharma, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.69
Actual
-$0.84
Surprise
-21.37%
Dr. Reddy's Laboratories Limited - ADR
Report Date
May 12, 2026 For Q4 26
Estimate
$11.40
Actual
$5.73
Surprise
-49.68%
Supernus Pharmaceuticals, Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$0.30
Actual
$0.60
Surprise
+97.69%
FAQ
What were Amphastar Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Amphastar Pharmaceuticals, Inc. reported EPS of $0.42, missing estimates by -41.59%, and revenue of $171.17M, -3.22% below expectations.
How did the market react to Amphastar Pharmaceuticals, Inc.'s Q1 2026 earnings?
The stock price moved down -20.93%, changed from $24.03 before the earnings release to $19.00 the day after.
When is Amphastar Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Amphastar Pharmaceuticals, Inc.'s next earnings report?
Based on 5
analysts, Amphastar Pharmaceuticals, Inc. is expected to report EPS of $0.72 and revenue of $186.13M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement